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Objective: perianeurysmal fibrosis (PAF) with involvement of neighbouring viscera can render open repair of inflammatory
aneurysms technically difficult and therefore hazardous. For this reason, endovascular repair (EVAR) has been advocated
as the preferred approach for this condition. EVAR is known to induce a systemic inflammatory response in patients but
the nature of the local response remains unknown. If significant, such a response could exacerbate rather than ameliorate
PAF. The aim of the study was to examine the incidence, course and consequences of perianeurysmal fibrosis detected by
computerised tomography (CT) before and after EVAR.
Material and Methods: the clinical records of patients treated by EVAR and followed for at least 6 months were
reviewed. Pre and post-operative CT images were independently graded for PAF by three radiologists according to a
standard protocol.
Results: PAF was documented preoperatively in six out of a total of 61 patients. In two of these PAF worsened after
EVAR resulting in ureteric obstruction and hydronephrosis requiring ureteric stents. In the remaining 4 patients PAF
did not reduce postoperatively. PAF of low grade developed postoperatively in 10 out of 55 patients (18%) in whom there
was no evidence of PAF on preoperative imaging. Median follow-up was 18 months (range 6–36 months). The development
of periaortic fibrosis de novo postoperatively was statistically significant (McNemar’s test; p=0.002).
Conclusion: EVAR does not seem to reverse PAF if this is present preoperatively and it induces this condition in
approximately one sixth of patients without evidence of preoperative PAF. The potential for this adverse inflammatory
local response should be taken into account when considering EVAR for treatment of aneurysms with perianeurysmal
fibrosis and must be weighed against the perceived benefits of this approach.
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Introduction In animals endovascular repair has been shown
to evoke an immediate local inflammatory response
Inflammatory abdominal aortic aneurysms (IAAA) around the stent-graft within the aneurysm and in the
perianeurysmal tissue.10,11 Longer-term evolution ofform a distinct clinical entity accounting for between
3 and 15% of all infrarenal aortic aneurysms.1–3 In- such periaortic inflammation has not been documented
previously in animal models or in humans. This studyvolvement of the ureter is seen in up to a quarter of
these patients.4 Conventional repair of IAAA can be was conducted to establish the incidence, extent and
implications of radiological changes consistent withchallenging and is associated with a higher mortality
and morbidity than repair of non-inflammatory an- inflammation in the perianeurysmal tissue following
EVAR.eurysms.5,6 Often the planes of surgical dissection are
obscured by fibrotic adhesions rendering the duo-
denum, the left renal vein and other adherent struc-
tures prone to iatrogenic injury.7 Endoluminal repair
can be performed without these risks in suitable Material and Methods
patients and has been proposed as a safer alterna-
tive.8,9 Details of all patients undergoing EVAR at our in-
stitution were entered prospectively into a computer
∗ Please address all correspondence to: P. L. Harris, Regional Vas- database. Patients with a minimum of 6 months follow-cular Unit, Link 8C, Royal Liverpool University Hospital, Prescot
Street, Liverpool, L7 8XP. up were entered into the study. Follow-up surveillance
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Table 1. Grading of periaortic fibrosis used in the study.
Grade 0 No fibrosis
Grade 1 Fibrosis <3 mm thick
Grade 2 Fibrosis 3–4 mm thick
Grade 3 Fibrosis 5–6 mm thick
Grade 4 Fibrosis 7–8 mm thick
Grade 5 Fibrosis >8 mm thick
demonstrates slight late enhancement with contrast
due to its abundant capillary network13 (Fig. 1).
In order to minimise the subjectivity inherent in
image analysis, a representative set of 6 images (Fig.
1) of aneurysms with varying degrees of periaortic
thickening, graded as shown in Table 1 was composed.
This set of images was used as reference throughout
Fig. 1. CT cross sections thorugh abdominal aortic aneurysms. (A) the study. Two Consultant radiologists (RGW and
Without perianeururysmal fibrosis, (B) Grade 1 perianeurysmal PCR) and one final year Higher Radiology Traineefibrosis, (C) Grade 3 perianeurysmal fibrosis and (D) Grade 5
(AA) interpreted all the films and reported in-perianeurysmal fibrosis.
dependently. Another author (SRV) collated the reports
to identify any discrepancies. In the event of dis-
of all patients had been conducted according to the agreement between reviewers, the images were re-
EURSOTAR12 protocol. This included dual phase con- evaluated by all reviewers together and a final con-
trast computerised tomography (CT) at 3, 6, 12, 18 and sensus was agreed in all cases. Discrepancy in the
24 months after operation and annually thereafter. Pre- grading of periaortic fibrosis of one grade only was
operative and follow-up CT images were reviewed for not subjected to this process. In this circumstance the
evidence of perianeurysmal fibrosis and the clinical majority opinion was accepted.
course of the patients was determined specifically
with reference to complications attributable to this
condition.
Statistical methods
McNemar’s test for paired data was applied to evaluate
Image interpretation the statistical significance of development of per-
ianeurysmal fibrosis de novo postoperatively.
Cross sectional CT images were studied for the pres-
ence or absence of periaortic fibrosis and the presence
of related complications such as ureteric obstruction.
ResultsThe degree and distribution of thickening due to fib-
rosis surrounding the aorta was also noted. The
A total of 61 patients were identified to have undergonemethodology and standardisation of reporting were
EVAR between February 1996 and June 1999, with atagreed at the outset and no changes were made sub-
least 6 months’ follow-up. Median duration of follow-sequently.
up was 18 months.Periaortic fibrosis was considered to be present if
there was thickening of the aortic wall outside the
ring of calcification (if present) or late contrast en-
hancement of the periaortic tissue that could not be Evaluation of CT images
interpreted as part of viscera. On CT cross section,
non-inflammatory aortic aneurysms appear to be com- There were major disagreements among the three
observers in relation to two patients. In one patient,prised of three layers; flow lumen of the aorta, non-
enhancing thrombus and a non-enhancing aortic wall. two observers found no perianeurysmal thickening at
any stage, while the third observer reported Grade 5In some patients thrombus is absent. Calcification is
usually seen to a variable extent within the wall. The thickening. Following re-evaluation of this set of im-
ages the consensus opinion was that the reportedpresence of periaortic inflammation or fibrosis gives
the appearance of an additional (fourth) layer on the periaortic thickening was in fact erroneous in-
terpretation of bowel adjacent to the aneurysm sac.outside of the aortic wall. Characteristically this layer
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Table 2. Evolution of periaortic fibrosis grading when noticed on preoperative imaging.
Grade of PAF at intervals after EVAR
Patient Pre-operative 3 months 6 months 12 months 18 months 24 months 36 months
A 5 5 5 5 5
B 4 4 4 4 4 4 4
C 1 3 3 3 3
D 1 1 1
E 2 2 2 2
F 1 1 1
(Gr 1=<3 mm, Gr 2=3–4 mm, Gr 3=5–6 mm, Gr 4=7–8 mm and Gr 5=>8 mm).
The final report for this patient was therefore that
there was no periaortic fibrosis at any stage. In another
patient, two observers reported Grade 1 periaortic
fibrosis in the preoperative scan. The third observer
who originally reported absence of fibrosis agreed to
the presence of Grade 1 fibrosis at the consensus
reporting.
The remaining 59 patients had a total of 241 sets of
CT scans reported. Among these there were minor
disagreements in relation to 9 sets. In all cases this
was resolved by one observer revising his grading of
fibrosis by one grade to comply with the grading of
the other two where the reports were in agreement.
Fig. 2. Patient A. CT scans showing Grade 4 perianeurysmal fibrosisPatients without perianeurysmal fibrosis at any stage (Image A) and bilateral ureteric stents (Image B) before operation.
There was no resolution of fibrosis at 17 months after operation
(Image C) and recurrence of hydronephrosis following stent removalIn 45 patients there was no perianeurysmal fibrosis at
(Image D).any stage before or after operation.
stents were removed after 3 months but bilateral
hydronephrosis recurred with gross dilatation of bothPatients with pre-operative perianeurysmal fibrosis
pelvicalyceal systems at 17 months (Fig. 2). This re-
quired replacement of ureteric stents while on con-Six patients were considered to have periaortic fibrosis
tinued steroid therapy.on preoperative imaging. Among these patients, two
were diagnosed preoperatively on clinical and imaging
grounds to have inflammatory aneurysms. The peri- Patient B. This 57-year-old woman underwent un-
aortic fibrosis in the remaining four was noted on complicated endovascular repair of a 50 mm in-
retrospective review. The severity of periaortic fibrosis flammatory AAA with a Vanguard stent-graft (Boston
of these patients before repair and during follow-up Scientific Corp, NJ, U.S.A.). Preoperative imaging re-
is presented in Table 2. A brief history of each of these vealed Grade 4 periaortic fibrosis with partial ob-
patients is given here. struction of the left ureter and mild dilatation of the
pelvicalyceal system. She was therefore commenced
on oral steroid therapy. The perianeurysmal fibrosisPatient A. This 71-year-old man underwent en-
dovascular repair with an AneuRx stent-graft (Med- remained at Grade 4 but the ureteric obstruction and
hydronephrosis worsened so that it became necessarytronic Inc, CA, U.S.A.) following a diagnosis of
inflammatory aneurysm. Preoperative bilateral uret- to insert a double J ureteric stent 6 months after
operation. The ureteric stent was removed 6 monthseric obstruction was relieved by placement of double
J stents and steroid therapy commenced. Preoperative later without recurrence of hydronephrosis despite the
fact that Grade 4 perianeurysmal fibrosis persisted atfilms showed Grade 5 perianeurysmal fibrosis and this
was still present 24 months after operation. The ureteric 36 months after operation.
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Fig. 4. Perianeurysmal fibrosis (PAF) developing de novo: No PAF
on preoperative CT scan (Image A), but noted at 1 month (Image
B), 3 months (Image C, short arrow pointing to duodenum) and 6
months (Image D) with gradual worsening.
follow-up images up to 6 months showed Grade 1
perianerurysmal fibrosis on review. He died 8 months
postoperatively of unrelated cause.
Fig. 3. Patient C: CT scans showing localised Grade 1 perianeurysmal
Patient E. This 56-year-old underwent endovascularfibrosis (Image A) and normal kidneys (Image B) before operation.
Perianeurysmal fibrosis had worsened significantly by 9 months repair of a 54 mm aneurysm using a Vanguard (Boston
after operation (Image C) and this was associated with development Scientific Corp, NJ, U.S.A.) device. A preoperativeof right hydronephrosis (Image D). Perianeurysmal fibrosis had not
diagnosis of inflammatory aneurysm was not made.reduced more than two years after operation.
The perianeurysmal fibrosis was of Grade 2 pre-
operatively and showed no signs of resolution at 18
Patient C. This man underwent uncomplicated endo- months after operation.
vascular repair of a 95 mm aneurysm with an AneuRx
stent-graft (Medtronic Inc, CA, U.S.A.) at the age of Patient F. This 63-year-old male underwent repair of
71 years. This was not diagnosed as inflammatory a 55 mm aneurysm that was not clinically diagnosed
before operation but on retrospective review, Grade 1 to be inflammatory, using an Excluder device (WL
periaortic fibrosis was noted on preoperative imaging. Gore Associates, AZ, U.S.A.). The preoperative and
A persistent primary endoleak fed by lumbar arteries postoperative images up to 6 months after the oper-
was noted and treated by coil embolisation 6 months ation showed Grade 1 perianeurysmal fibrosis.
after operation. By this stage established inflammatory
change (Grade 3) surrounding the aneurysm was noted
on CT with right ureteric involvement and resultant
hydronephrosis necessitating ureteric stent placement Patients without preoperative perianeurysmal fibrosis
(Fig. 3). An endoleak fed by the inferior mesenteric
artery was subsequently diagnosed on contrast en- Among the remaining 55 patients who did not have
perianeurysmal thickening on preoperative imaging,hanced Duplex scanning and CT at 12 months after
operation and this was ligated laparoscopically fol- 10 (18%) developed evidence of this condition on
follow-up imaging. An example is given in Fig. 4.lowing a failed attempt at embolisation. The peri-
aneurysmal fibrosis showed no signs of reducing at Grading and evolution of the postoperative fibrosis in
these patients is given Table 3. The maximal aneurysm24 months after operation.
diameter decreased in 6 of these patients while it
remained the same in two and increased in two. TherePatient D. This 76-year-old male patient underwent
EVAR with an AneuRx stent-graft (Medtronic Inc, CA, was no relationship between postoperative change in
aneurysm diameter and the development of peri-U.S.A.). A preoperative diagnosis of inflammatory
aneurysm was not made but his preoperative and all aneurysmal fibrosis.
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Table 3. Grading of periaortic fibrosis that developed de novo after EVAR and its evolution.
Grade of PAF at intervals after EVAR
Patient 3 months 6 months 12 months 18 months 24 months 36 months
A 1 3
B 1 1 1
C 1 1 1
D 1 1 0
E 1 0 0
F 3 5 0
G 2 1 0 0
H 1 0 0 0 0 0
I 2 1 1 1 0
J 2 1 0 0 0 0
(Gr 1=<3 mm, Gr 2=3–4 mm, Gr 3=5–6 mm, Gr 4=7–8 mm and Gr 5=>8 mm).
Table 4. Summary of results (No. of patients).
Fibrosis post-EVAR No fibrosis post-EVAR
Fibrosis pre-EVAR 6 0
No fibrosis pre-EVAR 10 45
Case report fibrosis. It is accepted that after open repair the peri-
aneurysmal fibrosis usually regresses.14,15 This is notOne of these ten patients developed late clinical com-
plications that resulted in his death. He had undergone necessarily the case after endovascular repair.
Endovascular repair of AAA is known to induceendovascular repair of a 60 mm aneurysm with a
Stentor endograft (Mintec Inc, La Ciatot, France) at a local inflammatory response.10,11 The explanations
considered for this include expression of a local im-the age of 76 years. There was no evidence of peri-
aneurysmal fibrosis preoperatively. At 6 months after mune reaction and this is also one of the theories
proposed to explain the aetiology of inflammatoryoperation there was evidence of Grade 5 peri-
aneurysmal fibrosis that had disappeared at 12 months. aneurysms. The longer-term effects of this local in-
flammatory response have not previously been docu-There was no ureteric involvement at any stage. He
died of sepsis 24 months after EVAR at another hos- mented.
pital. Postmortem examination revealed pneumonia
and an infected aortic stent-graft.
The other 9 patients with periaortic fibrosis that
developed de novo after operation have remained free Discussion of the methods employed
from clinical complications.
A summary of the results is shown in Table 4. The Despite using established parameters for reporting
probability that perianeurysmal fibrosis developing de periaortic fibrosis,16 it is acknowledged that the in-
novo after operation was observed by chance was terpretation of CT images is relatively subjective. To
calculated as less than less than 2 in 1000 (McNemar’s minimise the risk of error and bias all films were
test; p<0.002). The risk of developing perianeurysmal reported by three radiologists independently and any
fibrosis de novo was calculated to be 16.4% (95% CI disagreements resolved by group discussion. This
6.6%–27.1%). happened only in two patients where the senior ra-
diologists gave identical reports while the more junior
member diagnosed the presence of periaortic thick-
ening on one occasion and its absence in another.Discussion
Among the remaining 241 sets of images, 232 were
interpreted identically by all three observers. The re-The option of repairing an inflammatory aortic an-
eurysm by endoluminal means is attractive because it maining nine had two observers reporting identically
but the third grading the fibrosis lower by one grade.might be expected to reduce the operative risk com-
pared to open repair. This supposes that endoluminal There was therefore a high degree of concurrence
among the observers and good adherence to acceptedexclusion of the aneurysm has a beneficial effect on
or at least does not make worse the perianeurysmal standards of reporting.
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McNemar’s test for paired data showed strong stat- with EVAR compared to open repair might justify this
approach in some poor operative risk patients withistical significance for the observation of de novo peri-
aneurysmal fibrosis after endovascular repair. inflammatory aneurysms. But on the basis of this study
‘‘inflammatory’’ aneurysm may also be regarded asHowever the clinical ‘‘significance’’ of this study lies
in the fact that none of the inflammatory aneurysms a relative contra-indication to EVAR. Certainly the
potential disadvantages associated with exacerbationtreated showed a resolution of fibrosis. This together
with the finding that a high proportion (10/46) of non- of the inflammatory process must be weighed carefully
against the perceived benefits.inflammatory aneurysms developed periaortic fibrosis
de novo after EVAR signals the need for caution in
advising this method for the treatment of patients with
Other patientsestablished inflammatory aneurysms.
Among the 55 patients who had no periaortic fibrosis
noted on preoperative images, 10 patients (Table 3)
Aneurysms with perianeurysmal fibrosis preoperatively (18%) developed periaortic thickening de novo during
treated by endoluminal stent-graft follow-up. This tended to be mild in most with some
evidence of later regression. However as seen in two
Six of the 61 patients in this series had preoperative patients, it can be moderately severe. This study dem-
perianeurysmal fibrosis based on CT findings. Fol- onstrates for the first time that perianeurysmal fibrosis
lowing conventional repair of an inflammatory aortic may develop de novo after EVAR with a risk of one
aneurysm, the inflammatory change seen on imaging in six. Figure 3 demonstrates one such patient. The
and systemic markers of inflammation regress in the long-term implications of such stent-graft induced per-
majority of the patients.14,15 In this series of patients iaortic fibrosis are not known. The distribution of
treated with EVAR there was no evidence of regression fibrosis is similar to that seen in inflammatory an-
of fibrosis on imaging during follow-up ranging from eurysms. Associated clinical complications were not
6 to 36 months (Table 2 and Fig. 4). In one patient observed in any of these patients. However the risk
with an IAAA, the ureteric obstruction which was this might occur cannot be discounted.
present preoperatively remained troublesome after The exact pathogenesis of perianeurysmal fibrosis
operation with continued requirement for ureteric in patients with inflammatory aneurysm remains un-
stenting. Another patient with IAAA was able to tol- known. Similarly any theories about the mechanisms
erate post-operative removal of the ureteric stent even responsible for the observations made in this study
though there was no significant reduction in periaortic are at this stage speculative. One possibility is that the
fibrosis. Both these patients received steroid therapy. intraluminal devices themselves elicit a foreign body
In four patients in this series, inflammatory change reaction despite the fact that the materials used in
was diagnosed retrospectively on the basis of CT scans. their construction are inert. But it is also interesting
One of these patients developed ureteric obstruction to speculate about the role of the intra-sac thrombus.
postoperatively due to increased fibrosis. Intra-sac thrombus or products of thrombus de-
Reversal of the fibrotic response is a significant gradation have been implicated as a possible trigger
component of the aim of treatment of inflammatory of perianeurysmal fibrosis perhaps by eliciting an
aneurysms. In none of the 6 patients with preoperative autoimmune response. If this was true, it would not
periaortic fibrosis in this study was there any reduction be surprising to find that EVAR, which, in contrast to
in thickness of fibrosis on postoperative imaging with open repair, leaves the thrombus in-situ is not followed
follow-up ranging from 6 months to 36 months. This by regression of the inflammatory response. Also by
suggests an ‘‘on-going’’ inflammatory process. Al- eliciting new thrombosis in the sac EVAR might be
though endovascular repair is perhaps a lower risk expected to trigger de novo fibrosis in susceptible
option in suitable patients in the short term, it appears patients.
to be ineffective at reversing perianeurysmal fibrosis.
There are previous case reports of successful treat-
ment of patients with inflammatory aneurysm by Conclusion
EVAR with resolution of systemic inflammatory
markers.8,9 However in our series none of the patients Although the potential for lower operative risk com-
pared to open repair makes EVAR an attractive optionwith preoperative periaortic fibrosis demonstrated
radiological evidence of remission of fibrosis. The for the treatment of inflammatory aneurysms this
study shows that it may exacerbate the inflammatoryexpected lower mortality and morbidity associated
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